Prescribing Newsletter
COVID-19 & ACE-inhibitors or ARBs
NICE has published COVID-19 rapid evidence summary: angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) in people with or […]
COVID-19 & NSAIDs – NICE Advice
NICE has published a COVID-19 rapid evidence summary on Long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) for people with or at […]
COVID-19 – NE&Y eRD Support Programme
The Primary Care team for NHS England & NHS Improvement in the North East and Yorkshire have set up an […]
COVID-19 – Ibuprofen & NSAIDs Advice from NICE, MHRA & NHSEI
The Chief Executives of NICE & the MHRA and the National Medical Director for NHS England & NHS Improvement have […]
COVID-19 – Medicines for End of Life & Critical Care – RESOURCES
Resources to Support Appropriate & Equitable Supply & Use of Medicines for End of Life & Critical Care during the […]
COVID-19 – Warfarin
The NHS Specialist Pharmacy Service have published a guide to Management of patients taking warfarin during the COVID-19 pandemic. [See […]
COVID-19 – Anticoagulant Services Clinical Guide
NHSE&I have published a Clinical guide for the management of anticoagulant services during the coronavirus pandemic – as part of […]
COVID-19 – Drug Monitoring Guidance
The NHS Specialist Pharmacy Service have published Guidance on management of drugs requiring monitoring during COVID-19 – supported by background advice […]
COVID-19 – Smoking Cessation Services & Advice
The UK Government & Public Health England have highlighted that emerging evidence from China shows smokers with COVID-19 are 14 […]